Compile Data Set for Download or QSAR
maximum 50k data
Found 512 with Last Name = 'kallus' and Initial = 'c'
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089691(CHEMBL3577425)
Affinity DataIC50:  1nMAssay Description:Inhibition of CBP (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089758(CHEMBL3577442)
Affinity DataIC50:  1nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089688(ANABAENOPEPTIN B)
Affinity DataIC50:  1.5nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089687(Anabaenopeptin F)
Affinity DataIC50:  1.5nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089686(CHEMBL3577334)
Affinity DataIC50:  1.90nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183942(US9150526, 205)
Affinity DataIC50:  2nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50197573(CHEMBL3912764)
Affinity DataIC50:  3nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120796(US8710232, 33)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089691(CHEMBL3577425)
Affinity DataIC50:  3nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089755(CHEMBL3577439)
Affinity DataIC50:  4nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183959(US9150526, 222)
Affinity DataIC50:  4nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089751(CHEMBL3577435)
Affinity DataIC50:  4nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089756(CHEMBL3577440)
Affinity DataIC50:  4nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183901(US9150526, 154)
Affinity DataIC50:  5nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183758(US9150526, 7)
Affinity DataIC50:  5nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173886(US9688645, 1-1)
Affinity DataIC50:  6nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183943(US9150526, 206)
Affinity DataIC50:  6nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089749(CHEMBL3577433)
Affinity DataIC50:  7nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183761(US9150526, 10)
Affinity DataIC50:  7nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089691(CHEMBL3577425)
Affinity DataIC50:  7nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins in presence of 1% human serum albumin by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173906(US9688645, 3-1)
Affinity DataIC50:  7.70nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183902(US9150526, 155)
Affinity DataIC50:  8nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183949(US9150526, 212)
Affinity DataIC50:  8nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173904(US9688645, 2-1)
Affinity DataIC50:  8.80nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173918(US9688645, 5-2)
Affinity DataIC50:  9nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089750(CHEMBL3577434)
Affinity DataIC50:  9nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183918(US9150526, 176)
Affinity DataIC50:  10nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183944(US9150526, 207)
Affinity DataIC50:  10nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120790(US8710232, 17)
Affinity DataIC50:  11nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183801(US9150526, 51)
Affinity DataIC50:  11nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50197580(CHEMBL3933831)
Affinity DataIC50:  12nMAssay Description:Inhibition of activated human plasma TAFI incubated for 15 mins by chromogenic assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173923(US9688645, 6-3)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120788(US8710232, 15)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120787(US8710232, 13)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183955(US9150526, 218)
Affinity DataIC50:  12nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183954(US9150526, 217)
Affinity DataIC50:  13nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183947(US9150526, 210)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183938(US9150526, 201)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183843(US9150526, 96)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089748(CHEMBL3577432)
Affinity DataIC50:  15nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM50089742(CHEMBL3577426)
Affinity DataIC50:  15nMAssay Description:Inhibition of human activated TAFI incubated for 15 mins by microtiter plate reader based assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120786(US8710232, 12)
Affinity DataIC50:  15nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM120782(US8710232, 7)
Affinity DataIC50:  16nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183818(US9150526, 71)
Affinity DataIC50:  16nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183844(US9150526, 97)
Affinity DataIC50:  16nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B2(Homo sapiens (Human))
Institute For Infection Research

Curated by ChEMBL
LigandPNGBDBM173908(US9688645, 4-1)
Affinity DataIC50:  17nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI Activity Kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183904(US9150526, 157)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183912(US9150526, 169)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183939(US9150526, 202)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183940(US9150526, 203)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 512 total ) | Next | Last >>
Jump to: